Switching from prednisolone to dexamethasone in difficult-to-treat rheumatoid arthritis
Rheumatology (Oxford)
.
2024 Jan 4;63(1):e15-e16.
doi: 10.1093/rheumatology/kead334.
Authors
Floor Kerstens
1
,
Karin Spijkers
2
,
David Wolthuis
3
,
Maarten Boers
4
,
Noortje van Herwaarden
5
6
,
David Ten Cate
5
Affiliations
1
Department of Rheumatology, Radboudumc, Nijmegen, The Netherlands.
2
Department of Pharmacy, Sint Maartenskliniek, Nijmegen, The Netherlands.
3
Department of Endocrinology, Radboudumc, Nijmegen, The Netherlands.
4
Department of Epidemiology and Data Science, Amsterdam UMC, Amsterdam, The Netherlands.
5
Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.
6
Division of Pharmacology and Toxicology, Department of Pharmacy, Radboudumc, Nijmegen, The Netherlands.
PMID:
37421380
DOI:
10.1093/rheumatology/kead334
No abstract available
MeSH terms
Arthritis*
Arthritis, Rheumatoid* / drug therapy
Dexamethasone / therapeutic use
Humans
Prednisolone / therapeutic use
Substances
Prednisolone
Dexamethasone